MY145565A - Injectable preparations of diclofenic and its pharmaceutically acceptable salts - Google Patents

Injectable preparations of diclofenic and its pharmaceutically acceptable salts

Info

Publication number
MY145565A
MY145565A MYPI20070514A MY145565A MY 145565 A MY145565 A MY 145565A MY PI20070514 A MYPI20070514 A MY PI20070514A MY 145565 A MY145565 A MY 145565A
Authority
MY
Malaysia
Prior art keywords
injectable preparations
diclofenic
pharmaceutically acceptable
water
diclofenac
Prior art date
Application number
Inventor
Patel Ketan Rajnibhai
Paten Milan Rajnibhai
Original Assignee
Troikaa Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Troikaa Pharmaceuticals Ltd filed Critical Troikaa Pharmaceuticals Ltd
Priority to MYPI20070514 priority Critical patent/MY145565A/en
Publication of MY145565A publication Critical patent/MY145565A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

INJECTABLE PREPARATIONS OF DICLOFENIC AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS 5 'ME PRESENT INVENTION PROVIDES INJECTABLE FORMULATIONS OF WATER-SOLUBLE SALTS OF DICLOFENAC IN SINGLE DOSES OF LESS THAN 2 ML, WHICH CAUSE SIGNIFICANTLY LESS PAIN AT THE SITE OF INJECTION AND CAN BE ADMINISTERED BY INTRADELTOID ROUTE, IN ADDITION TO INTRAGLUTEAL AND SLOW INTRAVENOUS ROUTE. MORE SPECIFICALLY THE INJECTABLE PREPARATIONS CONTAIN 75 MG TO 100 MG OF 1 0 WATER-SOLUBLE SALTS OF DICLOFENAC, IN ABOUT I ML INJECTION SOLUTION WITHOUT SIGNIFICANTLY RAISING THE VISCOSITY OF THE INJECTION SOLUTION WITHOUT THE USE SURFACTANTS. THE FORMULATIONS ARE ADJUSTED TO PH 6 TO 10 CONTAINING UP TO 100MG OF DICLOFENAC SALT IN A MEDIUM COMPRISING OF WATER, ALONG WITH ONE OR MORE CO-SOLVENT(S) / SOLUBILISER(S), ANTIOXIDANTS, PRESERVATIVES, BUFFERS, ALKALI AND STABILIZERS. 20M 0*QLO'@
MYPI20070514 2007-04-02 2007-04-02 Injectable preparations of diclofenic and its pharmaceutically acceptable salts MY145565A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI20070514 MY145565A (en) 2007-04-02 2007-04-02 Injectable preparations of diclofenic and its pharmaceutically acceptable salts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20070514 MY145565A (en) 2007-04-02 2007-04-02 Injectable preparations of diclofenic and its pharmaceutically acceptable salts

Publications (1)

Publication Number Publication Date
MY145565A true MY145565A (en) 2012-02-29

Family

ID=45891273

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20070514 MY145565A (en) 2007-04-02 2007-04-02 Injectable preparations of diclofenic and its pharmaceutically acceptable salts

Country Status (1)

Country Link
MY (1) MY145565A (en)

Similar Documents

Publication Publication Date Title
ES2553742T3 (en) Pharmaceutical dosage form comprising 6'-fluor- (N-methyl- or N, N-dimethyl) -4-phenyl-4 ', 9'-dihydro-3'H-spiro [cyclohexane-1,1'-pyran [3,4, b] indole] -4-amine
CY1122516T1 (en) READY-TO-USE FORMULATIONS OF KETOROLAK
MY208749A (en) Biligand drug conjugates and uses thereof
MX2025005489A (en) Novel methods
ECSP109905A (en) 7 TYPE TOLL RECEIVER MODULATORS
WO2010053655A3 (en) Therapeutic methods with withaferin a and analogs
EP4378482A3 (en) Dosing regimens for anti-cd30 vc-pab-mmae antibody drug-conjugates
PH12014500386A1 (en) Combination treatment for hepatitis c
EP4299093A3 (en) Wearable automatic injection device for controlled administration of therapeutic agents
MX2010002392A (en) Improved brimonidine compositions for treating erythema.
MX2009013835A (en) Stabilized picoplatin dosage form.
NZ595767A (en) Composition for the treatment of prostate cancer
ES2720954T3 (en) Statin Stabilized Formulations
NZ700182A (en) Parenteral formulations for administering macrolide antibiotics
MX2016011333A (en) Drug delivery systems and methods for treatment of bladder cancer with gemcitabine.
PE20181332A1 (en) METHODS OF SEDATION AND PARENTERAL FORMULATION FOR USE DURING THE TREATMENT OF CRITICAL CARE
MX2009005798A (en) Stroke recovery.
AR080096A1 (en) COMBINED TREATMENT OF PANCREAS CANCER WITH GEMCITABIN AND MASITINIB
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use
WO2007133796A3 (en) Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist
MX2007009312A (en) Injectable preparations of diclofenic and its pharmaceutically acceptable salts.
NZ591496A (en) A medicinal comprising ibuprofen and paracetamol and treatment for arthritis
CL2008001332A1 (en) Use of temozolomide to prepare a drug useful for the treatment of a proliferative disorder.
NZ587941A (en) Methods to inhibit tumor cell growth by using lansoprazole
MX2010003594A (en) Crystalline forms of dmxaa sodium salt.